Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Emotional difficulties were consistently elevated among children and young people from low income households over a month of lockdown compared to those from higher income households.

Young child looking out of a window

The most recent report from the Co-SPACE (COVID-19 Supporting Parents, Adolescents, and Children in Epidemics) study highlights that:

  • Emotional and restless/attention difficulties (and behaviour difficulties for primary school aged children) were consistently elevated among children and young people from low income households over a month of lockdown compared to those from higher income households, with around two and a half times as many children experiencing significant problems in low income households.
  • Parents and carers from low income households reported that their children (aged 4 to 16 years) had higher levels of emotional difficulties, such as feeling unhappy, worried, being clingy and experiencing physical symptoms associated with worry than those from higher income households. Their children were also more fidgety and restless and had greater difficulty paying attention. Those with younger, primary school aged children also reported that their children were experiencing higher levels of behaviour difficulties, including temper tantrums, arguments and not doing what they were being asked to do by adults than those from higher incomes.

Read more about the report findings on the Department of Experimental Psychology website

The story is also available on the University of Oxford website

Similar stories

Oxford-led team given £6.6m to map uncharted networks in the progression of Parkinson’s

A major new $9 million (£6.6 million) project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. It is the only UK-led ASAP project this year, and the first ever to be led by Oxford.

Tamoxifen repurposing study shows no benefit in treating deadly fungal meningitis

Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by the results of a clinical trial conducted by University of Oxford researchers and published today in eLife.

Oxford researchers awarded funding to complete community COVID-19 antiviral trial

Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.

New therapeutic targets identified to treat inflammatory bowel disease

Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.

Oxford researchers call for an urgent re-evaluation of “weak” opioid safety profile

A new study associates dispensation doses of tramadol with increased risk of mortality, cardiovascular events, and fractures compared to the use of codeine to treat pain.

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.